A Report from the 34th Annual European Academy of Dermatology and Venereology (EADV) Congress.
Key takeaways from the 2025 EADV Congress in Paris, including the IPC Symposium on psoriasis, Free Communication…
Key takeaways from the 2025 EADV Congress in Paris, including the IPC Symposium on psoriasis, Free Communication…
View ReportIPC Councilor Dr. Fernando Valenzuela explains how phototherapy can be effectively used to treat psoriasis in pediatric…
Watch VideoEn este video de Take Ten con IPC, el Dr. Fernando Valenzuela analiza la conexión entre la salud oral y la psoriasis,…
Watch VideoIn this Take Ten with IPC video, Dr. Fernando Valenzuela explores the connection between oral health and psoriasis,…
Watch VideoEl Dr. Fernando Valenzuela analiza las ventajas y desventajas de la fototerapia como opción de tratamiento para…
Watch VideoREUNIÓN ANUAL DE DERMATÓLOGOS LATINOAMERICANOS (RADLA) | LIMA, PERÚ Tuesday, May 7 09:00– 12:00 PET Program…
IPC stands for accessible treatment and universal healthcare on World Psoriasis Day and beyond. Gain insights from…
Read MoreDr. Fernando Valenzuela discusses how he treats nail psoriasis in his daily practice. El Dr. Fernando Valenzuela…
Watch VideoThe IPC’s global network of experts generously volunteers their time every year to educate and train other physicians…
Read MoreREUNIÓN ANUAL DE DERMATÓLOGOS LATINOAMERICANOS (RADLA) | CURITIBA, BRAZIL Friday, May 26 14:00 – 17:00 BRT 13:00…
La XXXIX Reunión Anual de Dermatólogos Latinoamericanos (RADLA) se realizó de manera virtual del 2 al 5 de mayo,…
Read MoreIt is not fully understood the impact that COVID-19 has on psoriasis patients. .
Read MoreBiologics and biosimilars have created many new options in psoriasis treatment for patients worldwide, but patients…
Read MoreView Report
Latin American countries view biosimilar agents as an effective approach to curtail health-care expenditures while…
View Report| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
IPC Councilor Helen Young provides commentary on a study identifying skin-derived myeloid precursors and CD200+ fibroblasts as key drivers of psoriatic disease spread from the skin to joints, highlighting the CD200–CD200R1 axis as a promising therapeutic target.
IPC Fellow Dr. Yemsrach Abawaji shares her firsthand perspective on the barriers to psoriasis diagnosis and treatment in Ethiopia and opportunities to improve care.
Did you miss the IPC symposium at the 83rd Society for Investigative Dermatology (SID) Annual Meeting? Select session videos are now available. The Arc of Disease Control in Psoriasis: Early Interception – Deep Pathway Blockade – Treatment Failure covered early intervention strategies, treatment selection, immune pathway targeting, PsA prevention, clinical escape, and real-world cases that inform long-term psoriasis care.
Depression affects approximately 20% of patients with psoriasis, five times the rate seen in the general population. IPC Jr. Councilor Mio Nakamura, MD, MS, FAAD, walks through the bidirectional relationship between psoriasis and depression, the shared inflammatory pathways driving both conditions, and practical guidance on screening and incorporating multidisciplinary mental health support into psoriasis management.